• Formazione
  • Protocolli Covid-19
  • Multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19)

Multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19)

Istituto Nazionale Tumori, IRCCS, Fond. G. Pascale - Napoli

(Data Parere Unico CE 18-03-2020)

TOCIVID-19 documenti